Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo (Q83938445)
Jump to navigation
Jump to search
scientific article published on 22 April 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo |
scientific article published on 22 April 2011 |
Statements
Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo (English)
Yan Li
Sheng Zhao
Wei Zhang
Peng Zhao
Bing He
Na Wu
22 April 2011